Here Are Tuesday’s Top Wall Street Analyst Research Calls: Amgen, Baidu, Best Buy, Circle Internet, Corning, Intel, Lockheed Martin SpaceX, TeraWulf and More
📉 Amgen was downgraded to Market Perform from Outperform by BMO Capital.
💰 BMO Capital maintains a $450 price target for Amgen shares following the rating change.
📅 The analyst action took place on Tuesday, September 8, 2026, as part of a daily roundup of Wall Street research calls.
Risk Factors
- Amgen was downgraded to Market Perform from Outperform by BMO Capital, signaling reduced analyst confidence in the company's near-term prospects.
- The downgrade occurred while the broader market faced pressure from strong employment data that increased the likelihood of a Federal Reserve rate hike.
Full Analysis
Amgen (AMGN) received a downgrade to Market Perform from Outperform at BMO Capital on Tuesday, September 8, 2026. The analyst firm adjusted its rating for the biotech giant while maintaining a price target of $450 per share.
This negative analyst action occurred amidst a broader market environment where Wall Street returned from summer vacation to brace for potential Federal Reserve rate hikes following strong August payrolls data that crushed expectations.
The downgrade represents a shift in sentiment regarding the company's outlook, contrasting with other recent analyst moves in the sector such as upgrades for Intel and Lockheed Martin, though specific fundamental drivers for Amgen's downgrading were not detailed in this report.
